Haemonetics Corporation (HAE)
Debt-to-assets ratio
| Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Long-term debt | US$ in thousands | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Total assets | US$ in thousands | 2,450,950 | 2,531,270 | 2,525,220 | 2,540,980 | 2,195,590 | 2,200,430 | 2,011,280 | 1,962,260 | 1,934,820 | 1,878,070 | 1,865,110 | 1,820,530 | 1,859,730 | 1,831,380 | 1,801,500 | 1,794,190 | 1,819,920 | 1,318,070 | 1,418,170 | 1,433,170 |
| Debt-to-assets ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
March 31, 2025 calculation
Debt-to-assets ratio = Long-term debt ÷ Total assets
= $—K ÷ $2,450,950K
= 0.00
The debt-to-assets ratio for Haemonetics Corporation has consistently remained at 0.00 for the period from June 30, 2020, to March 31, 2025. This indicates that the company has not used any debt financing to fund its assets during this time frame. A debt-to-assets ratio of 0.00 suggests that the company's assets are entirely financed by equity, which can be seen as a positive signal to investors and creditors, as it implies lower financial risk and a stronger financial position. It also indicates that the company may have sufficient internal funds or positive cash flows to support its operations and investment activities without relying on borrowing. However, it is important to consider that a low debt-to-assets ratio may also indicate missed opportunities for leveraging cheap debt for potential expansion or growth strategies.
Peer comparison
Mar 31, 2025